Annual Drug Patent Expirations for ABILIFY+MYCITE+KIT Abilify Mycite Kit is a drug marketed by Otsuka and is included in one NDA. It is available from one supplier. There are thirty-one…
The post Patent delisted for Otsuka drug ABILIFY MYCITE KIT appea…
Patent delisted for Otsuka drug ABILIFY MYCITE KIT Read Post »
Annual Drug Patent Expirations for LONSURF Lonsurf is a drug marketed by Taiho Oncology and is included in one NDA. It is available from one supplier. There are five patents…
The post Patent delisted for Taiho Oncology drug LONSURF appeared first on Dr…
Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from four suppliers. There are six patents…
The post Patent delisted for Boehringer Ingelheim drug JARDIANCE a…
Patent delisted for Boehringer Ingelheim drug JARDIANCE Read Post »
Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from four suppliers. There are six patents…
The post Patent delisted for Boehringer Ingelheim drug JARDIANCE a…
Patent delisted for Boehringer Ingelheim drug JARDIANCE Read Post »
Annual Drug Patent Expirations for TARGINIQ Targiniq is a drug marketed by Purdue Pharma Lp and is included in one NDA. There are fifteen patents protecting this drug. Drug patent…
The post Patent delisted for Purdue Pharma drug TARGINIQ appeared first…
Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…
The post Patent delisted for Boehringer Ingelheim drug OFEV appeared first on…
Patent delisted for Boehringer Ingelheim drug OFEV Read Post »
Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from two suppliers. There are eleven patents…
The post Patent delisted for Boehringer Ingelheim drug GLYXAMBI ap…
Patent delisted for Boehringer Ingelheim drug GLYXAMBI Read Post »
Annual Drug Patent Expirations for ENVARSUS+XR Envarsus Xr is a drug marketed by Veloxis Pharms Inc and is included in one NDA. It is available from one supplier. There are…
The post Patent delisted for Veloxis Pharms drug ENVARSUS XR appeared first on…
Patent delisted for Veloxis Pharms drug ENVARSUS XR Read Post »
Annual Drug Patent Expirations for AMPYRA Ampyra is a drug marketed by Acorda and is included in one NDA. It is available from two suppliers. Drug patent litigation for AMPYRA.…
The post Patent delisted for Acorda drug AMPYRA appeared first on DrugPate…
Annual Drug Patent Expirations for AMPYRA Ampyra is a drug marketed by Acorda and is included in one NDA. It is available from two suppliers. Drug patent litigation for AMPYRA.…
The post Patent delisted for Acorda drug AMPYRA appeared first on DrugPate…